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Ly6Chi inflammatory monocytes 
promote susceptibility to 
Leishmania donovani infection
Cesar Terrazas1, Sanjay Varikuti1, Steve Oghumu2, Heidi M. Steinkamp3, Nurittin Ardic1,5, 
Jennifer Kimble1, Hira Nakhasi4 & Abhay R. Satoskar1,6
Ly6Chi inflammatory monocytes (iMO) are critical for host defense against toxoplasmosis and malaria 
but their role in leishmaniasis is unclear. In this study, we report a detrimental role of Ly6Chi iMOs in 
visceral leishmaniasis (VL) caused by Leishmania donovani. We demonstrate that Ly6Chi iMOs are 
continuously recruited into the spleen and liver during L. donovani infection and they are preferential 
targets for the parasite. Using microarray-based gene expression profiling, we show that Ly6Chi 
iMOs isolated from the infected liver and spleen have distinct phenotypic and activation profiles. 
Furthermore, we demonstrate that blocking the recruitment of Ly6Chi iMOs into the liver and spleen 
during L. donovani infection using a CCR2 antagonist reduces the frequency of the pathogenic IFN-γ/
IL10 dual producer CD4+ T cells in the spleen and leads to a significant reduction in parasite loads in the 
liver and spleen. Using STAT1−/− mice we show that STAT1 is critical for mediating the recruitment 
of Ly6Chi iMOs into organs during L. donovani infection, and adaptive transfer of wild type Ly6Chi iMOs 
into STAT1−/− recipients renders them susceptible to disease. Our findings reveal an unexpected 
pathogenic role for Ly6Chi iMOs in promoting parasite survival in VL and open the possibility of targeting 
this population for host-directed therapy during VL.
Visceral leishmaniasis (VL) is the second leading cause of mortality among tropical diseases. It is caused by 
Leishmania donovani in Asia and Africa and L. infantum in South America and the Mediterranean basin. L. dono-
vani is an obligate intracellular protozoan that infects professional phagocytes such as neutrophils, macrophages, 
dendritic cells, and spreads systemically infecting the spleen, liver and bone marrow1. As of yet, there is no vac-
cine available, and current drug treatments have adverse side effects, such as liver and pancreatic damage, and in 
some cases, death. Investigating the mechanisms that L. donovani exploits in order to survive in the host is highly 
relevant so as to understand disease progression and design new therapies.
It is well established that protective immunity against VL involves a Th1-associated response characterized by 
the IL12-IFNγ-iNOS pathway, which is necessary for optimal macrophage activation and formation of granulo-
mas2,3. STAT1 is an important transcription factor that mediates IFNγ signaling and is central to the development 
of a Th1 immune response. Surprisingly, mice that are genetically deficient in STAT1, although unable to mount 
a Th1 immune response, are highly resistant to VL4. Mechanisms surrounding STAT1 mediated susceptibility 
to VL caused by L. donovani have remained incompletely understood, but previous studies suggest that T cell 
independent mechanisms are involved. Understanding the cellular mechanisms surrounding the resistance of 
STAT1−/− mice to VL will provide insights into L. donovani pathogenesis in the host and provide new strategies 
for treatment against VL.
At the cellular level, L. donovani preferentially infects Kupffer cells in the liver and marginal zone macrophages 
in the spleen5. Newly recruited macrophages which are derived from circulating monocytes are also potential 
host cells and play a crucial role in the establishment of L. donovani infection. These circulating monocytes are 
divided into two subsets: patrolling monocytes (characterized as CD11b+ CX3CR1lo Ly6Clow CCR2- CD115+) 
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and inflammatory monocytes iMOs (characterized as CD11b+ CX3CR1lo Ly6Chi CCR2+ CD115+)6. iMOs exit 
the bone marrow in a CCR2 dependent manner, and once in circulation, they infiltrate the tissue3. iMOs are 
activated after pathogen recognition through Toll like receptors (TLRs) and/or IFNγ signaling and produce nitric 
oxide as well as inflammatory cytokines such as TNFα. Finally, iMOs differentiate into macrophages or dendritic 
cells (TipDCs) with enhanced microbicidal activity and are indispensable for resistance to a variety of pathogens7. 
Since the activation and subsequent differentiation of iMOs depends in part on STAT1 mediated IFNγ signaling, 
it is essential that we understand the role of this immune cell subset during infection with L. donovani.
iMOs play an important role in immunity against intracellular pathogens8. They have been shown to drive 
strong Th1 immune responses and protection against murine Toxoplasma infection9,10. Further, blockade of iMOs 
migration from the bone marrow to infected sites results in increased susceptibility to Listeria monocytogenes in 
mice3. iMOs are associated with protection against Plasmodium vivax11, although they also contribute to brain 
pathology in a mouse model of experimental cerebral malaria. In Leishmania major infection, iMOs have also 
been shown to play a protective role12. In this study, we investigated the role of iMOs during VL. In contrast to 
most intracellular pathogens, our results reveal a detrimental role for this immune cell subset. Our results also 
provide an explanation for the previously observed surprising resistance to L. donovani infection that is observed 
in STAT1−/− mice.
Results
Dynamics of inflammatory monocyte recruitment during VL. A variety of infections cause the 
recruitment of iMOs into infected tissues which results in pathogen clearance13,14. During murine VL, mono-
cytes are recruited into the liver resulting in the formation of granulomas during early and chronic phase of the 
infection. However, what is not known is the kinetics of such monocyte recruitment, and whether the infiltrate 
consists of Ly6Chi iMOs. In order to investigate the early phase of the immune response during VL, we studied 
the mobilization of iMOs into L. donovani infected organs. To this end, we identified iMOs as CD11b+ Ly6Chi 
Ly6G− by flow cytometry. The proportion of iMOs increased after 24h post infection (pi) in the liver and spleen 
(Fig. 1A). Next, we investigated the kinetics of iMO recruitment. We found constant accumulation of iMOs in the 
Figure 1. Leishmania donovani infection induced preferential recruitment of inflammatory monocytes.  
(A) Flow cytometric analysis of CD11b+ gated cells from the spleen and liver of L. donovani infected mice at 24 
hr post infection. (B) Kinetics of inflammatory monocyte recruitment was evaluated by flow cytometry at the 
indicated time points in spleen and liver. Data represents the mean ± SEM from 1 of 2 independent experiments 
(n = 5/time point). L donovani-DsRED parasites were inoculated i.p. into WT mice, 24 h later peritoneal 
exudates were evaluated by Imaging-flow cytometry. Infected cells were gated as shown in (C) and analyzed 
for Ly6C and Ly6G expression (D). (E) Percentages of different subsets of infected cells, MO: Ly6Chi Ly6G-
CD11b+, PMN: Ly6C+ Ly6G+ CD11b+, and Dneg: Ly6C-Ly6G-CD11bhi+ (n = 3). (F) Representative pictures 
of the different subsets infected with L. donovani analyzed by AMNIS Flow sight.
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liver and spleen over time reaching up to 15–25% of myeloid cells in both organs after 30 days of post infection 
(dpi) (Fig. 1B). We next investigated the ability of iMOs to phagocytize L. donovani parasites. Using transgenic 
DsRED–L. donovani parasites, we looked for infected cells after 24h of inoculation in the peritoneal cavity. We 
found three subsets infected with L. donovani. The cells harboring more parasites were Ly6Chi Ly6G−CD11b+. 
The second population of infected cells consisted of Ly6C+ Ly6G+ CD11b+ neutrophils. Interestingly, resident 
Ly6C-Ly6G-CD11b+ macrophages were also infected, however they represented the least infected cells among 
the three populations (Fig. 1C–F). Taken together, L. donovani infection resulted in early and continuous recruit-
ment of iMOs into liver and spleen with high capability to uptake Leishmania parasites.
Characterization of inflammatory monocytes recruited during L. donovani infection. In order 
to confirm the identity of CD11b+ Ly6ChiLy6G- cells observed during L. donovani infection, we examined the 
expression of CD115 (MCSF receptor) and the hallmark chemokine receptor CCR23. These cells expressed 
CD115 and CCR2 on their cell surface, which is in agreement with the phenotype described for inflammatory 
monocytes15, (Fig. 2A). In some infections, inflammatory monocytes gain CD11c expression and are known as 
TipDCs16,17. However, during chronic infection with L. donovani, iMOs did not upregulate CD11c, but expressed 
intermediate levels of MHCII and F4/80 on their membrane (Fig. 2A), which is suggestive of their differentiation 
into the macrophage lineage. iMOs are known to express high levels of iNOS in several infections, and nitric 
oxide production is important in L. donovani resistance18. Interestingly iNOS expression was higher in liver than 
in the spleen after 30 dpi, and a similar trend was found for TNFα expression. Unlike iNOS, arginase is associated 
with Leishmania survival inside macrophages19. iMOs isolated from the spleen at 30 dpi showed higher arginase 
expression compared to liver isolated iMOs (Fig. 2B). Interestingly, arginase/iNOS ratio was higher in the spleen 
where the infection turns progressive, and the opposite trend was found in the liver where the infection starts 
resolving after 30 dpi (Fig. 2C). It appears from these data that, unlike the liver, the splenic microenvironment 
causes differentiation of iMOs into a phenotype that favors Leishmania survival. Recently, it was reported that 
iMOs can produce PGE2 depending on the gut microbiota20. COX2, an upstream regulator of PGE2 production 
was slightly overexpressed by iMOs in both the liver and the spleen (Fig. 2B)
Inflammatory monocytes isolated from spleen and liver during VL present differential acti-
vation state. The uncommon arginase expression in monocytes isolated from spleen (Fig. 2C) lead us to 
expand the characterization of those iMOs by using microarray based gene expression profiling. Among the top 
upregulated genes, we found S100A9, S100A8 and CXCL9 (Fig. 3F). S100A8/9 functions as a chemoattractant for 
Figure 2. Characterization of inflammatory monocytes phenotype during Leishmania donovani infection. 
(A) Flow cytometric analysis of Ly6ChiLy6G-CD11b+ cells from uninfected and L. donovani infected WT 
mice 30 days post infection. Cells were gated on CD11b+ and analyzed for monocyte/macrophages/DC 
associated markers. Representative overlaid histograms plots were shown. (B) Gene expression analysis of 
sorted Ly6ChiLy6G-CD11b+ cells from spleen and liver of L. donovani infected mice. Data represents fold 
change relative to sorted cells from uninfected mice. Bar graphs show the average gene expression of pooled 
Ly6ChiLy6G-CD11b+ cells sorted from infected mice (n = 4). (C) Gene expression ratio of Arginase:iNOS from 
Ly6Chi Ly6G- CD11b+ cells sorted from livers and spleens.
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monocytes and neutrophils, while CXCL9 attracts CXCR3 expressing cells such as T and NK cells. These chemok-
ines are enhanced with IFN stimulation21. Also, we found upregulation of IFN signaling pathway by increased 
expression of IRF1 and IGR1. Interestingly, when we compared IRF1 and IRG1 we found higher expression in 
the liver than in the spleen, which is opposite compared with S100A8/9 expression (Fig. 3F). Further, pathway 
analyses using Ingenuity Pathway Analysis software revealed other characteristics of iMOs, such as up regulation 
of antigen presentation associated genes and interferon signaling and complement activation in splenic iMOs 
after infection (Fig. 3C). Interestingly, splenic iMOs showed enhanced ubiquitination pathway protein expression 
and enhanced expression of oxidative phosphorylation which has been associated with M2 macrophage metabo-
lism (Fig. 3C,D)22, which is in line with our observation of splenic iMOs expressing elevated arginase transcripts 
(Fig. 2B). Upstream analysis revealed a role for IFNs, STAT1, TLRs, IL1B and IL-6 as main regulators for iMOs 
gene expression (Fig. 3A,B). To identify key molecules involved in iMO phenotype, we generated a pathway for 
iMO, interestingly; STAT1 pointed was a key player in iMOs phenotype (Fig. 3E).
STAT1 is necessary for iMO accumulation in spleen and liver during L. donovani infection. The 
central roles of STAT1 in the genome profile of iMOs lead us to investigate them in STAT1KO mice. Previously 
we found that STAT1 KO mice were highly resistant to VL in a T cell independent fashion4. Some studies have 
shown that IFNs could be important for monocyte differentiation in an IRF dependent pathway23. The main IFNγ 
intracellular signaling adaptor is STAT1. However, the role STAT1 plays in monocyte accumulation is unknown. 
We first investigated the accumulation of iMOs in STAT1 KO mice. As showed before (Fig. 1A) WT mice had 
enhanced accumulation of CD11b+ Ly6ChiLy6G- cells. Interestingly, spleens and livers of L. donovani infected 
STAT1KO mice showed profound defect in Ly6C monocyte accumulation (Fig. 4A,B). We then hypothesized 
that the defect in monocyte recruitment may account for the ability of STAT1 KO mice to efficiently control 
Figure 3. STAT1 is a key molecule in iMOs phenotype. Ly6Chi Ly6G-CD11b+ cells were sorted from the 
pooled spleen suspensions of naïve or 30 dpi mice (n = 4). RNA obtained from sorted cells was analyzed in 
Affymetrix microarray chip. Data was analyzed with Ingenuity pathways analysis software, and upstream 
regulators and networks were constructed. (A) Top upstream cytokine regulators on infected iMOs. (B) Top 
transcription factors found by IPA analysis. (C) Top canonical pathways associated with iMOs infection. (D) 
Network of genes involved in top 10 upstream regulators. (E) STAT1 network in infected iMOs. (F) Validation 
of up regulated genes by RT-PCR, represented fold increase is compared to WT un-infected controls. Bar graphs 
show the average gene expression of pooled Ly6ChiLy6G-CD11b+ cells sorted from infected mice (n = 4).
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L. donovani infection. To test this hypothesis, we transferred bone marrow Ly6Chi WT monocytes into STAT1 
KO mice on 1 dpi. After 20 days of infection STAT1KO mice that received WT monocytes showed two times 
more parasites in the spleen than control STAT1 KO mice (Fig. 4C). However, we did not find differences in 
parasitic loads in the liver (data not shown). Splenocytes from STAT1 KO mice proliferated more than those 
from WT mice after Leishmania antigen re-stimulation. However, the proliferation of STAT1 KO splenocytes was 
slightly reduced by transferred WT iMOs (Fig. 4D). WT infected mice produced enhanced levels of IFNγ and 
IL-10 in splenocyte culture supernatants upon L. donovani Antigen (LdAg) stimulation. In contrast, the culture 
supernatants from STAT1 deficient mice showed reduced levels of IFNγ and IL-10 (Fig. 4G,H). Strikingly, we 
observed significantly higher levels of IL-17 production from STAT1KO mice compared to the WT mice (Fig. 4I). 
Interestingly, STAT1 KO mice that received WT monocytes recovered IL-10 production and showed impaired 
IL-17 production. In line with other reports showing a relationship between IL-17 levels and neutrophil accumu-
lation we found significantly lower neutrophil frequencies in spleens and livers of STAT1 KO mice that received 
WT monocytes compared with their controls (Fig. 4E,F).
Blocking iMO accumulation decreases parasitic loads in liver and spleen. Our data showed 
that deficient recruitment of iMOs in STAT1KO mice improved resistance to VL. Monocytes egress from the 
bone marrow in a CCR2 dependent fashion3. In order to block monocyte migration into the infected tissues we 
administrated a CCR2 specific antagonist RS-504393, as was previously used in a fibrosis model24. We injected 
CCR2 antagonist once daily from day 1 to day 29 pi (CCR2A) and another group once daily from day 20 to 
day 30 pi (CCR2B). Both modes of RS-504393 administration effectively reduced the numbers of inflammatory 
monocytes in spleens and livers (Fig. 5A,E) without affecting the frequency of the CD115+ Ly6Clo population 
(Fig. 5B,F). These findings strongly suggest that iMOs accumulated during VL were bone marrow derived and 
their migration was CCR2 dependent. Interestingly, mice which received RS-504393 presented less splenomegaly 
and hepatomegaly compared with control mice (Fig. 5C,G). Importantly, blocking iMOs accumulation by CCR2 
Figure 4. STAT1 plays a critical role in iMO accumulation in L. donovani infected tissues. (A) Flow cytometric 
analysis of Ly6Chi cells from the spleen of L. donovani infected WT and STAT1KO mice at 20 dpi. (B) Flow 
cytometric analysis of Ly6Chi cells from the liver of L. donovani infected WT and STAT1KO mice at 20 dpi. 
(C) Bone marrow iMOS were sorted from naïve WT mice and transferred into L. donovani infected STAT1KO 
mice at 24 h pi, Parasitic loads were analyzed at 20 dpi. (D) Splenocytes were re-stimulated with L. donovani 
antigen for 72 h, proliferation was avaluated by using Alamar Blue. (E,F) Percentages of Ly6Chi (Ly6Chi 
Ly6G- CD11b+), Ly6Clow (Ly6Clow Ly6G-CD11b+) and PMN (Ly6C+ Ly6G+ CD11b+) in spleen and liver 
respectively. (G–I) Supernatants from antigen re-stimulated splenocytes were evaluated for IFNγ, IL-10 and 
IL-17 production by ELISA. Data represented from 1 of 3 independent experiments. n = 5, *p < 0.05.
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antagonist resulted in significantly decreased parasitic loads in spleens and livers (Fig. 5D,H). A previous study 
by Sato et al.25 had found genetically resistant C57BL/6 mice lacking CCR2 develop similar parasitic burdens 
compared to WT upon L. donovani infection. Although Sato et al. did not examine the impact of CCR2 defi-
ciency on iMOs recruitment to organs, these observations suggest that CCR2 and possibly iMOs recruited to the 
organs may not play a critical role in immunity against L. donovani. In an independent experiment by using lucif-
erin expressing parasites, we also confirmed that CCR2 antagonist treatment successfully reduced the parasitic 
loads in livers, spleens and lymph nodes of L. donovani infected mice (Fig. 5I,J). Additionally, livers from mice 
treated with RS-504393 showed no granuloma formation irrespective of the period of RS-504393 administration 
(Supplementary Figure 1).
CCR2 inhibition decreased IFNγ IL-10 double producers CD4+ T cells. In order to investigate if the 
absence of iMOs affected the host immune response, we evaluated the cytokine profile of CCR2 inhibitor treated 
mice. We found that CCR2 inhibitor administration resulted in decreased IL-10 production by splenocytes inde-
pendent of the time of administration of CCR2 antagonist (Fig. 6A). Interestingly, CCR2 inhibitor administra-
tion had no effects on IFNγ and slightly, but not significantly, decreased IL-4 production, leaving the Th1/Th2 
response intact (Fig. 6C,B). IL-10 was significantly diminished when we administered CCR2 antagonist, corre-
lating with disappearance of inflammatory monocytes (Fig. 5A,E). However, we did not observe up-regulation of 
IL-10 mRNA in inflammatory monocytes in the spleen (Fig. 2B), suggesting that iMO could be influencing other 
cells to produce IL-10. In order to evaluate the source of IL-10, we performed intracellular cytokine staining of 
splenocytes from chronically infected mice. We found a CD4+ T cell population positive for both IFNγ and IL-10 
(Fig. 6D). This population has been reported to be responsible for non-healing lesions during L. major infection 
and with the progression of VL26,27. In our experiments, RS-504393 treated mice showed reduced numbers of 
IFNγ IL10 double producer CD4+ T cells (Fig. 6D,E) and correlated with decreased IL-10 production found in 
splenocyte supernatants (Fig. 6A). We also noticed that antigen specific splenocyte proliferation was enhanced 
in RS-504393 treated mice (Fig. 6H). In line with this, administration of CCR2 antagonist resulted in enhanced 
Figure 5. Administration of CCR2 antagonist reduced monocyte recruitment and parasitic loads. L. donovani 
infected mice were treated with CCR2 antagonist RS-504393, once daily from day 1 to day 30 pi (CCR2A) or 
once daily from day 20 to day 30 pi (CCR2B) respectively. Flow cytometry analysis of frequencies of Ly6Chi cells 
in spleen (Fig. 5A) and liver (Fig. 5E). Flow cytometry analysis of frequencies of Ly6Clow cells in spleen (Fig. 5B) 
and liver (Fig. 5F). Data shown is from one of the three experiments (n = 4). Spleen weight (Fig. 5C) and liver 
weight (Fig. 5G) percentages of body weight were represented at 30 dpi. Combined data from two independent 
experiments N = 8, *p < 0.05 **p = 0.01 ***p = 0.001. (I,J) Representative images and Kinetics of Luciferin-
expression L. donovani was analyzed by IVIS imaging system at the indicated time points. Data representative of 
the mean ± SEM of photons/second/cm2 (n = 3).
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frequencies of CD4+ T cells (Fig. 6G) and comparable numbers of CD4+ IFNγ+ cells in the spleen (Fig. 6F). 
The splenocytes of CCR2 antagonist received mice also showed increased T cell proliferation upon L. donovani 
antigen stimulation (Fig. 6H).
Discussion
In contrast with other infectious diseases, we found here that iMOs accumulated during VL and served as a con-
tinuous source of host cells for L. donovani parasite infection. Early recruited iMOs during VL did not show the 
classical activation profile, and lacked iNOS, TNFα, as well as expression markers for dendritic cells. iMOs from 
chronic infection demonstrated polarized profiles towards an inflammatory phenotype (iNOS) in the liver and 
an anti-inflammatory phenotype (arginase) in the spleen. This suggests that early contact with L. donovani is not 
able to trigger iMO activation and their polarization requires further help from the adaptive immune response. 
In mice, L. donovani profoundly infects the liver in the first 3–4 weeks and then the infection is resolved via an 
IL-12-IFNγ-iNOS dependent axis18,28. In the spleen the infection is chronic, progressive and does not resolve. 
This correlates with the high levels of iNOS we observed in liver iMOs which may partly account for their ability 
to kill the parasites and resolve liver infection29. On the other hand, higher arginase expression in splenic iMOs 
could potentially facilitate parasite growth and avoid its elimination.
It must be noted that blocking iMO accumulation was sufficient to avoid parasite establishment in the liver 
and spleen. This suggests that iMOs promote VL primarily as initiators of L. donovani establishment. Supporting 
this idea, we showed that STAT1 was required for iMO accumulation. This explains the resistant phenotype of 
STAT1 KO mice even in the absence of IFNγ signaling. It appears from this data that although STAT1 signaling is 
generally protective against VL, in some cases it can be detrimental, and could cause the accumulation of host res-
ervoir cells for L. donovani infection4. STAT1 may participate in the differentiation of monocytes since IFNs play 
a role in monopoiesis23. IFNs are also important for the upregulation of integrins that facilitate iMO migration 
through the endothelia and tissues and by enhancing chemokine expression30. However, the exact mechanism of 
STAT1-mediated monocyte accumulation during VL requires further research.
iMOs require TLR or IFNγ stimulation to become activated. In contrast, the presence of IL-10 impairs their 
differentiation into TipDCs31. The ability of L. donovani to subvert TLR and IFNγ signaling and enhance IFNγ/
Figure 6. CCR2 antagonist reduced percentages of IFNγ+ IL10+ double producer CD4 cells. Splenocytes 
were harvested from L. donovani infected, CCR2A, CCR2B and vehicle treated mice at 30 dpi, re-stimulated 
with LdAg for 72 h, and release of cytokines was evaluated in the culture supernatants. (A) IFNγ, (B) IL-4 and 
(C) IL-10 release was evaluated by ELISA. (D) Representative dot plots showing IFNγ and/or IL10 production 
by CD4+ gated cells. Analysis of (E) frequencies of IFNγ IL-10 double producers CD4+ cells in the spleen, 
(F) IFNγ CD4+ producers cells, and (G) total CD4+ cells n = 4. (H) Proliferation analysis by alamar blue of 
splenocytes stimulated 72 h with L. donovani antigens. n = 5, *p < 0.05 **p = 0.01.
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IL10 producer CD4+ T cells can explain the inability of iMOs to become fully activated during VL. The iMO 
phenotype found in VL was in striking contrast to that found during cutaneous leishmaniasis, where iMOs dif-
ferentiated into TipDCs with high nitric oxide production and leishmanicidal activity32. It has been proposed 
that the tissue microenvironment may control the immune response33, but parasites can also directly modify the 
behavior of innate myeloid cells34. In our study we still do not understand what causes the differences observed 
in monocyte polarization in the liver and spleen during VL, but it is possible that tissue-derived factors may play 
a role in regulating iMO activation.
Our results demonstrate as a proof of concept that blocking iMOs results in reduced parasitic loads during 
L. donovani infection. Importantly the absence of iMOs negatively affected the numbers of IFNγ/IL10+ CD4+ 
T cells which are also dependent on the presence of CD11c+ DCs and play a detrimental role during VL27. 
Interestingly, blocking iMO recruitment reduced granuloma formation. Although the formation of granulomas 
is important for L. donovani elimination from the liver, it has been shown that L. donovani elimination can be 
achieved in absence of granulomas35. The high expression of CXCL9 and S100A8/9 may account for the ability of 
iMOs to recruit neutrophils, monocytes and T cells into the infected site and shape granuloma formation.
In conclusion, our data provide evidence of a novel mechanism by which L. donovani successfully establishes 
infection in the host, which relies on the recruitment of iMOs. In this experimental VL model, these cells are 
critical for sustaining L. donovani infection by functioning as a host cell reservoir for the parasite, in addition to 
modulating the host immune response. However, it must be noted that there are significant differences between 
the well-established experimental VL model used in this study and human VL, which could have an impact on 
the significance of our results to human disease. For one thing, the intravenous injection of L. donovani amas-
tigotes into mice contrasts with the natural sand-fly mediated cutaneous route of transmission of L. donovani 
promastigotes in humans. This obviously affects the nature of local and systemic immune responses involved in 
immunity to the human disease. Nevertheless, our novel findings underscore the importance of a unique immune 
cell subset that mediates the establishment of L. donovani infection in mice, which can potentially be exploited in 
the prevention and treatment of VL.
Materials and Methods
Animals. STAT1−/− (C.129S-Stat1〈tm1Dlv〉) mice were generated as described previously4. 8–10 weeks old 
female BALB/c mice were purchased from Envigo (previously Harlan laboratories, Indianapolis, IN, USA). All 
experimental mice were maintained in vivarium at The Ohio State University in compliance with the guidelines 
of OSU ULAR. All experimental procedures were performed according to the approved experimental protocol 
2010A0048-R2 by The Ohio State University institutional guidelines for animal research (OSU-IACUC).
Parasites and infection protocol. Leishmania donovani (LV82 strain) amastigotes were isolated from the 
spleen of previously infected Golden Syrian hamsters. Red fluorescent protein expressing DsRed2 transgenic L. 
donovani LV82 parasites were obtained from infected stock mice as described previously36. All experimental mice 
were infected with 107 L. donovani LV82 or DsRed2 LV82 amastigotes by tail vein injection. Groups constituted of 
three or five mice and were sacrificed at different time points post-infection for further analysis.
Parasite burden calculation. At different time points during the infection, livers and spleens were har-
vested, weighed, and impression smears were taken. Smears were stained with Giemsa stain (Sigma-Aldrich, 
St. Louis, MO, USA). Parasite loads were counted under a microscope by a certified pathologist. Parasitic loads 
were expressed as Leishmania donovani Units (LDU) = Number of amastigotes per 1000 nucleated cells × organ 
weight (grams).
Treatment of mice. To evaluate the role of CCR2 inflammatory monocytes, we administered a CCR2 
antagonist RS-504393 (R&D systems, Minneapolis, MN, USA) intraperitoneally. One group of mice received 
RS-504393 (2 mg/kg i.p.) one day after infection daily for 29 days (CCR2 A), second group received RS-504393 (2 
mg/kg i.p) daily from days 20–30 dpi (CCR2 B). Control mice were injected with PBS intraperitoneally.
Cytokine ELISA and Alamar blue proliferation assay. Splenocytes isolated from WT and STAT1−/− 
mice were plated at a concentration of 0.5 × 106 cells per well in quadruplicates in 96-well tissue culture plates 
(Thermo-Fisher Scientific, Waltham, MA, USA). Cells were then stimulated with 20 ug/ml of L. donovani antigen 
(LdAg) prepared by freeze-thawing L. donovani promastigotes. Supernatants were collected after 72 h of incu-
bation and analyzed for the production of IFN-γ, IL-4, IL-6, IL-10, IL-13 and IL-17 by ELISA (all capture and 
detection antibodies were purchased from Biolegend, San Diego, CA, USA) and recombinant mouse standards 
were purchased from BD Biosciences (San Jose, CA, USA). For proliferation assays 10% Alamar blue (Life tech-
nologies, Carlsbad, CA) was added 48h after stimuli and readings were taken after additional 18 hours of incuba-
tion. Data represent fluorescence units calculated by subtracting the fluorescence of unstimulated controls versus 
L. donovani stimulated cells. ELISA plates were read at an absorbance of 405 nm, and for Alamar blue, plates were 
read at 570 and 600nm using Spectramax M3 microplate reader (Molecular Devices LLC, Sunnyvale, CA, USA) 
and concentrations were determined by Softmax Pro software (Molecular Devices LLC, Sunnyvale, CA, USA).
Flow cytometry. Single cell suspensions from liver and spleen were collected gently extruding the tissues 
through a 70 uM cell strainer (BD Biosciences, San Jose, CA, USA). Blood was recovered from tail vein bleeding. 
Red blood cells were lysed with ACK lysis solution. One million cells were blocked with mouse serum and stained 
with different cocktail antibodies or their respective isotype controls for 20 minutes at 4 °C. Ly6C APC, Ly6G 
PE, CD11b FITC, CD62L PercP, MHCII PE, F480 PercypCy7, CD115 PercP, and iNOS PE were purchased from 
Biolegend (San Diego, CA, USA), and CCR2 Alexa 700 or FITC, Arginase APC from R&D systems (Minneapolis, 
MN, USA). For intracellular detection of iNOS and arginase, cell membrane was stained first and then fixed with 
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2% paraformaldehyde for 10 minutes. Cell permeabilization was carried out using Biolegend permeabilization 
buffer followed by 45-minute incubation with anti iNOS and anti-arginase antibodies. Flow cytometry was per-
formed using by BD FACSCalibur (San Jose, CA, USA) or Flowsight AMNIS (Seattle, WA, USA) cytometers. Cell 
sorting was performed using a BD FACS Aria (San Jose, CA, USA). Sorted Ly6Chi Ly6G-CD11b+ cells were iso-
lated from bone marrow of BALB/c naïve mice, and 1 × 106 Ly6C+ Ly6G-CD11b+ cells were transferred i.v. into 
STAT1 KO mice one day before Leishmania donovani infection. For monocyte and neutrophil functional assays, 
Ly6Chi Ly6G- CD11b+ or Ly6C+ Ly6G+ CD11b+ expressing cells were isolated from the spleens of naïve or 
infected mice. Data was analyzed using Flow jo software (FLOWJO, LLC, Ashland, OR, USA).
Real Time PCR. Total RNA was extracted from both the spleens and livers of experimental mice by TRIzol 
extraction method (purchased from Life technologies (Carlsbad, CA)), making sure to minimize any contaminat-
ing genomic DNA material. cDNA was prepared by iScript reverse transcriptase and RT PCR reactions were done 
by using IQ SYBR green super mix and a CFX 96 RT-PCR cycler (purchased from Bio-Rad, Hercules, CA, USA). 
Pre-validated primers were selected from the Primer bank website (http://pga.mgh.harvard.edu/primerbank) and 
are listed in Supplementary Table 1. Samples were run in technical triplicates, and appropriate positive and nega-
tive controls were included for each RT-PCR experiment. Data obtained were normalized using the housekeeping 
gene β-actin and presented as the fold induction over uninfected WT mice.
Microarray. Five ng of total RNA was amplified using the NuGen Ovation Pico WTA System V2 and labeled 
by using the NuGen Encore Biotin Module (San Carlos, CA, USA). The samples were then hybridized onto the 
Mouse Transcriptome arrays (MTA) for 16 hours at 45 °C. The samples were then washed and stained on the 
Affymetrix Fluidics 450 system according to manufacturer protocols and scanned on the Affymetrix GeneChip 
scanner 3000 7G (Sunnyvale, CA, USA).
Statistical analysis. Student’s unpaired t-test was used to determine statistical significance of differences in 
the values. A value of p < 0.05 was considered significant.
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